MeSH tree: G05.365.590.335.590
A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key features that may help predict which types of rare cancers are likely to respond to immunotherapy.
May 20, 2026
0
2
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to ...
Apr 7, 2026
0
10
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses and cheaper testing. But new research from the University of Warwick, published ...
Mar 2, 2026
0
41
A multicenter study has analyzed nearly 2,000 digitized tissue slides from colon cancer patients across seven independent cohorts in Europe and the US. The samples included both whole-slide images of tissue samples and clinical, ...
Aug 21, 2025
0
41
Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of anti-cancer drugs. The yet-to-be-published findings are presented on Friday at the 36th EORTC-NCI-AACR ...
Oct 24, 2024
0
17
In an editorial, in Oncoscience titled "Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy," researcher Ioannis A. Voutsadakis from Sault Area Hospital and Northern Ontario School of Medicine ...
May 13, 2024
0
31
A new research paper titled "XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis" has been published in Aging.
Jan 30, 2024
0
29
A new research paper titled "Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response" has been published in Aging.
Jan 17, 2024
0
35
A new research paper titled "Analytic validation of NeXT Dx, a comprehensive genomic profiling assay" has been published in Oncotarget.
Aug 30, 2023
0
33
Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center showed that patients with African ancestry had fewer actionable mutations than patients with European ancestry and were less ...
Apr 17, 2023
0
41
